Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q3 2015 · 10-Q
Revenue$8.15M$8.15M+74.5% vs Q3 2014 Net Income-$2.98M-$2.98MN/M vs Q3 2014 EPS Diluted-$0.11-$0.11N/M vs Q3 2014 Gross Profit$6,743,259+78.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,779,311N/M Free Cash Flowderived-$2,999,912N/M Margins · derivedGross margin82.7%+1.9 pt vs Q3 2014
Operating margin-23.5%+15.1 pt vs Q3 2014
Net margin-36.5%+32.8 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 5, 2015 · 36 d after period end